Equities Analysts Offer Predictions for Chemours Q1 Earnings

The Chemours Company (NYSE:CC) – Equities researchers at Zacks Research dropped their Q1 2026 earnings estimates for Chemours in a note issued to investors on Wednesday, March 4th. Zacks Research analyst Team now anticipates that the specialty chemicals company will earn ($0.09) per share for the quarter, down from their previous estimate of $0.20. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q4 2026 earnings at $0.13 EPS, FY2026 earnings at $1.06 EPS, Q3 2027 earnings at $0.52 EPS and FY2027 earnings at $1.97 EPS.

Chemours (NYSE:CC) last released its quarterly earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the previous year, the company earned $0.09 EPS. The firm’s revenue for the quarter was down 2.2% compared to the same quarter last year.

Other research analysts have also recently issued research reports about the company. Mizuho upped their target price on Chemours from $17.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, March 5th. Jefferies Financial Group reissued a “hold” rating and set a $17.00 price target on shares of Chemours in a research note on Monday, February 23rd. Morgan Stanley boosted their price objective on Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, February 23rd. Truist Financial upped their price objective on Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, January 21st. Finally, UBS Group lifted their target price on Chemours from $18.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Five equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.40.

Chemours Stock Up 6.1%

Shares of NYSE CC opened at $17.42 on Monday. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.78 and a quick ratio of 0.85. The company has a market cap of $2.61 billion, a P/E ratio of -7.02 and a beta of 1.60. Chemours has a 1 year low of $9.13 and a 1 year high of $21.85. The firm has a 50-day simple moving average of $16.48 and a two-hundred day simple moving average of $14.76.

Institutional Investors Weigh In On Chemours

Hedge funds have recently made changes to their positions in the company. Atlas Capital Advisors Inc. purchased a new position in shares of Chemours during the fourth quarter valued at $26,000. MTM Investment Management LLC purchased a new stake in Chemours in the second quarter worth about $27,000. Aster Capital Management DIFC Ltd purchased a new stake in Chemours in the fourth quarter worth about $28,000. Covestor Ltd grew its holdings in Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 1,748 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new position in Chemours during the 4th quarter worth about $31,000. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be issued a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 2.0%. The ex-dividend date is Friday, February 27th. Chemours’s dividend payout ratio (DPR) is presently -14.11%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.